title: Ibrutinib repurposing: from B-cell malignancies to solid tumors.
authors.affiliation: Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Massó-Vallés
authors.affiliation: Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
authors.forename: Toni
authors.initials: T
authors.lastname: Jauset
authors.affiliation: Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Soucek
keywords: BTK; drug repurposing; ibrutinib; inflammation; solid tumors